Dry eye treatment, reinvented.

LACRIFILL^® Canalicular Gel is changing practice and changing lives.

LIMITED-TIME OPPORTUNITY: Q4 Savings Are Available on LACRIFILL^®

Take advantage of special year-end savings through December 31, 2026. Connect with our team to learn more about current opportunities for your practice.

LEARN MORE

The Benefits of LACRIFILL^®

Learn More

Order LACRIFILL^®
Canalicular Gel Now!

Contact Us

Product Information

Eye Care Professionals

Reimbursement

All News

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

04/09/26

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025

10/16/25

Nordic Group B.V. Through its Subsidiary Nordic Pharma, Inc. (U.S.), Announces LACRIFILL® Canalicular Gel Inclusion in New Dry Eye Workshop (DEWS) III Management and Therapy Report From The Tear Film and Ocular Surface Society (TFOS) in American Journal of Ophthalmology

08/07/25